Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Selegiline

"Selegiline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.


This graph shows the total number of publications written about "Selegiline" by people in Harvard Catalyst Profiles by year, and whether "Selegiline" was a major or minor topic of these publication.
Bar chart showing 23 publications over 17 distinct years, with a maximum of 3 publications in 1998
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.